JPS627190B2 - - Google Patents
Info
- Publication number
- JPS627190B2 JPS627190B2 JP24087583A JP24087583A JPS627190B2 JP S627190 B2 JPS627190 B2 JP S627190B2 JP 24087583 A JP24087583 A JP 24087583A JP 24087583 A JP24087583 A JP 24087583A JP S627190 B2 JPS627190 B2 JP S627190B2
- Authority
- JP
- Japan
- Prior art keywords
- thiamine disulfide
- acid
- higher fatty
- thiamine
- disulfide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- GFEGEDUIIYDMOX-BMJUYKDLSA-N n-[(4-amino-2-methylpyrimidin-5-yl)methyl]-n-[(z)-3-[[(z)-2-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-5-hydroxypent-2-en-3-yl]disulfanyl]-5-hydroxypent-2-en-2-yl]formamide Chemical compound C=1N=C(C)N=C(N)C=1CN(C=O)C(\C)=C(CCO)/SSC(/CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N GFEGEDUIIYDMOX-BMJUYKDLSA-N 0.000 claims description 29
- 229960001385 thiamine disulfide Drugs 0.000 claims description 29
- 150000001875 compounds Chemical class 0.000 claims description 23
- 150000004665 fatty acids Chemical class 0.000 claims description 15
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 14
- 239000000194 fatty acid Substances 0.000 claims description 14
- 229930195729 fatty acid Natural products 0.000 claims description 14
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000013078 crystal Substances 0.000 description 11
- 238000002844 melting Methods 0.000 description 8
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 8
- 235000021355 Stearic acid Nutrition 0.000 description 7
- 230000008018 melting Effects 0.000 description 7
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 7
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 7
- 235000019157 thiamine Nutrition 0.000 description 7
- 239000011721 thiamine Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 6
- 229960003495 thiamine Drugs 0.000 description 6
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 6
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 5
- 235000019658 bitter taste Nutrition 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical compound [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 description 3
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 206010013911 Dysgeusia Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- RQFLGKYCYMMRMC-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O RQFLGKYCYMMRMC-UHFFFAOYSA-N 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 150000003544 thiamines Chemical class 0.000 description 2
- GTQXMAIXVFLYKF-UHFFFAOYSA-N thiochrome Chemical compound CC1=NC=C2CN3C(C)=C(CCO)SC3=NC2=N1 GTQXMAIXVFLYKF-UHFFFAOYSA-N 0.000 description 2
- QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229960001305 cysteine hydrochloride Drugs 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24087583A JPS60132964A (ja) | 1983-12-22 | 1983-12-22 | チアミンジスルフイドの付加化合物及びその製法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24087583A JPS60132964A (ja) | 1983-12-22 | 1983-12-22 | チアミンジスルフイドの付加化合物及びその製法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60132964A JPS60132964A (ja) | 1985-07-16 |
| JPS627190B2 true JPS627190B2 (enrdf_load_html_response) | 1987-02-16 |
Family
ID=17065991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP24087583A Granted JPS60132964A (ja) | 1983-12-22 | 1983-12-22 | チアミンジスルフイドの付加化合物及びその製法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60132964A (enrdf_load_html_response) |
-
1983
- 1983-12-22 JP JP24087583A patent/JPS60132964A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS60132964A (ja) | 1985-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU224212B1 (hu) | 5-[4-[2-(N-metil-N-(2-piridil)amino)etoxi]benzil]tiazolidin-2,4-dion-maleát és ezt tartalmazó gyógyszerkészítmények | |
| DE69606840T2 (de) | Monohydrate von Aminobenzensulfonsäurederivaten und Verfahren zu ihrer Herstellung | |
| EP3578546A1 (en) | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof | |
| EP3406610A1 (en) | Angiotensin ii receptor antagonist metabolite and nep inhibitor composite, and preparation method thereof | |
| BR112014018212B1 (pt) | Complexos de germânio com aminoácidos e ácidos carboxílicos e método de preparo dos mesmos | |
| EA011283B1 (ru) | Гидрохлорид дигидрат (s)-(-)-1-(4-фторизохинолин-5-ил)сульфонил-2-метил-1,4-гомопиперазина | |
| WO2014023682A1 (en) | Multicomponent crystalline system comprising deferasirox and isonicotinamide and a process for the preparation thereof | |
| CN103965116A (zh) | 半5-氟胞嘧啶盐、其制备方法及应用 | |
| AU2016269359B2 (en) | Sodium salt of uric acid transporter inhibitor and crystalline form thereof | |
| KR102576930B1 (ko) | 제2철 말톨의 결정질 형태 | |
| EP3390358B1 (en) | Crystalline eravacycline bis-hydrochloride | |
| JPS627190B2 (enrdf_load_html_response) | ||
| EP3792258B1 (en) | Addition salt of s1p1 receptor agonist and crystal form thereof, and pharmaceutical composition | |
| US10717729B2 (en) | Thiamine-organic acid salt | |
| JP2019089822A (ja) | トピロキソスタットの新規結晶形及びその製造方法 | |
| JP2878844B2 (ja) | Ｎ▲ｇ▼−モノメチル−ｌ−アルギニン塩酸塩誘導体および敗血性ショックの治療におけるこれらの使用 | |
| KR20210046028A (ko) | 트레프로스티닐의 에르부민 염 | |
| DE69106276T2 (de) | Säureadditionssalze einer optisch aktiven Alaninanilidverbindung und diese enthaltende, pharmazeutische Zusammensetzungen. | |
| JPH0234941B2 (enrdf_load_html_response) | ||
| EP4227305A1 (en) | Crystalline form of sotorasib | |
| JPS61289078A (ja) | ニコチン酸アミドと高級脂肪酸との付加化合物及びその製造法 | |
| JPS61100572A (ja) | １，３‐ビス（１ｈ‐１，２‐４‐トリアゾール‐１‐イル）‐２‐フルオロ‐２‐（２，４‐ジフルオロフエニル）プロパン、該化合物を含有する抗菌組成物、ならびに該化合物および該組成物の製造方法 | |
| AU2017217728A1 (en) | Crystalline modifications of N-(4,5-bismethanesulfonyl-2-methylbenzoyl)guanidine hydrochloride and N-(4,5-bismethanesulfonyl-2-methylbenzoyl)guanidine salts | |
| KR20230172013A (ko) | 트리엔틴 테트라하이드로클로라이드 및 이의 제조 방법 및 이의 조성물 | |
| CN110950910A (zh) | 一种稳定的米诺膦酸化合物 |